Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-02-23 @ 11:35 AM
Study NCT ID:
NCT01885195
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2013-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MEK162 for Patients With RAS/RAF/MEK Activated Tumors
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-20
First Submit QC Date:
None
Study First Post Date:
2013-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-02-02
Results First Submit QC Date:
None
Results First Post Date:
2021-02-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-11-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-02-02
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL